EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US
Abstract
Authors
R. Sandin D. Veenstra M. Dzingina M. Vankelegom S. Sullivan D. Campbell C. Ma C. Harrison F. Draica T.L. Wiemken T. Mugwagwa